2023Unpublished venueOpen access

Supplementary Table 1 from Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin

Dae‐Won Lee, Sae‐Won Han, Jeong Mo Bae, Hoon Jang, Hyojun Han, Hyoki Kim, Duhee Bang, Seung‐Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Tae‐You Kim

Open full text 0 citations

Abstract

Tumor mutation burden in MSI-H patients

About this research paper

What this paper is about

Tumor mutation burden in MSI-H patients

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Tumor mutation burden in MSI-H patients

Key concepts: Oxaliplatin, Colorectal cancer, Medicine, Oncology, Internal medicine, Adjuvant, Mutation, Cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Supplementary Table 1 from Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin — Research Paper | ScholarLens